• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酰胺、5-氟尿嘧啶、六甲蜜胺和泼尼松联合用于晚期乳腺癌的I-II期评估。

Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.

作者信息

Chang Y C, Falkson G, Tormey D C, Crowley J

出版信息

Cancer Clin Trials. 1981 Winter;4(4):377-80.

PMID:6797746
Abstract

A four-drug combination of intermittent high-dose cyclophosphamide with 5-fluorouracil, hexamethylmelamine, and prednisone was given to 19 patients with advanced breast cancer. Objective response was documented in 7 of 18 evaluable patients. The median duration of response was 99 days. Response was observed in 6/7 patients without visceral disease and 1/11 patients with visceral disease. Toxicity was acceptable and no life-threatening toxicity was observed. Three patients have received the four-drug combination for more than 1 year without serious side effects. This regimen may serve as an alternative treatment for patients without visceral metastasis who have failed to respond to other combination chemotherapy regimens.

摘要

对19例晚期乳腺癌患者给予间歇性大剂量环磷酰胺联合5-氟尿嘧啶、六甲蜜胺和泼尼松的四联疗法。18例可评估患者中有7例记录到客观缓解。缓解的中位持续时间为99天。在无内脏疾病的7例患者中有6例出现缓解,在内脏疾病患者的11例中有1例出现缓解。毒性是可接受的,未观察到危及生命的毒性。3例患者接受四联疗法超过1年且无严重副作用。对于对其他联合化疗方案无反应的无内脏转移患者,该方案可作为一种替代治疗方法。

相似文献

1
Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.环磷酰胺、5-氟尿嘧啶、六甲蜜胺和泼尼松联合用于晚期乳腺癌的I-II期评估。
Cancer Clin Trials. 1981 Winter;4(4):377-80.
2
Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.转移性乳腺癌的联合与序贯五药化疗对比研究
Cancer Res. 1976 Nov;36(11 Pt 1):3911-6.
3
Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.紫杉醇联合每周大剂量5-氟尿嘧啶/亚叶酸钙和顺铂治疗晚期乳腺癌。
Semin Oncol. 1996 Oct;23(5 Suppl 11):32-7.
4
Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.长春瑞滨、环磷酰胺和5-氟尿嘧啶联合治疗晚期乳腺癌的II期试验
In Vivo. 1998 Sep-Oct;12(5):559-62.
5
Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.
Cancer Treat Rep. 1979 Feb;63(2):307-9.
6
Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.
Cancer Treat Rep. 1980 Feb-Mar;64(2-3):323-6.
7
A five-drug combination in the treatment of metastatic breast cancer.一种用于治疗转移性乳腺癌的五药联合方案。
Cancer Clin Trials. 1981;4(1):81-5.
8
Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
Cancer Treat Rep. 1981 Jan-Feb;65(1-2):149-51.
9
Phase II study of hexamethylmelamine alone and in combination with mitomycin C and vincristine in advanced breast carcinoma.
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2053-6.
10
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
N Engl J Med. 1978 Dec 7;299(23):1261-6. doi: 10.1056/NEJM197812072992301.